<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01718106</url>
  </required_header>
  <id_info>
    <org_study_id>846/CE</org_study_id>
    <nct_id>NCT01718106</nct_id>
  </id_info>
  <brief_title>Single Long vs Two Short Overlapping Bioabsorbable Polymer DES</brief_title>
  <acronym>ROCCO</acronym>
  <official_title>Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent vs 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero Universitaria Maggiore della Carita</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero Universitaria Maggiore della Carita</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple overlapping drug-eluting coronary stents (DES) are usually needed to treat long
      coronary stenoses but this strategy is expensive and the response to overlapping DES has not
      been extensively studied. The recent availability of bioabsorbable polymer DES could allow
      treatment of long coronary stenoses without leaving gross burden of non-absorbable polymer in
      the vessel wall, even in case of overlapping stents.

      Thus we planned to evaluate which of the 2 strategies, namely using a single long
      biabsorbable DES or two shorter biabsorbable DES with minimal overlapping, is better in
      treating long coronary stenoses.

      The study is a spontanous randomized multicenter open-label study. A maximum of 300 patients
      with stable angina and at leat 1 coronary stenosis &gt;28mm and &lt;40mm of length will be
      randomized in 1:1 fashion by a Web-based electronic CRF. The long stent group (Group A) will
      be treated by a single 44mm Biomime DES (II generation DES with bioabsorbable polymer, Meril
      Life Sciences Pvt. Ltd., Gujarat, India). The short stent group (Group B) will be treated by
      2 short Biomime DES positioned with minimal overlapping. The primary end-point of the study
      will be the 6 moth in-stent late lumen loss. Seconadry end-points will be 1, 6 and 12 month
      overall mortality, myocardial infarction, target vessel revascularization, stent thrombosis
      and MACE (combination of the 3 previous clinical end-points). Patients will be evaluated by
      6-month control coronary angiography and late lumen loss in the stented vessel will be
      measured in a quantitative coronary angiography Core Lab (Cardioimaging Centre, Novara,
      Italy)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>follow up in-stent late lumen loss</measure>
    <time_frame>6-month</time_frame>
    <description>difference between the in-stent coronary lumen measure obtained immediately after coronary percutaneous intervention and the in-stent coronary lumen measure at follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall mortality</measure>
    <time_frame>1 year</time_frame>
    <description>mortality for all causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 year</time_frame>
    <description>Myocardial infarction (universal definition of myocardial infarction, ACC/AHA/ESC statement) in the territory of the treated coronary artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>target vessel revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>revascularization of the treated coronary vessel by repeated percutaneous coronary intervention or coronary artery bypass grafting due to restenosis and or symptoms or instrumental signs of myocardial ischemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>2 years</time_frame>
    <description>Coronary stent thrombosis according to ARC definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE (major coronary adverse event)</measure>
    <time_frame>1 year</time_frame>
    <description>combined endpoint = presence of overall death or myocardial infarction or target vessel revascularization or stent thrombosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Single long bioabsorbable polymer DES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with long coronary stenosis treated by a single long bioabsorbable polymer DES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two bioabsorbable polymer DES in overlapping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with long coronary artery stenosis tretaed by 2 bioabsorbable polymer DES with minimal overlapping</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>implantation of a bioabsorbable polymer DES</intervention_name>
    <description>implantation in patients with long coronary artery stenosis of a single long or two shorter overlapped bioabsorbable polymer DES</description>
    <arm_group_label>Single long bioabsorbable polymer DES</arm_group_label>
    <arm_group_label>Two bioabsorbable polymer DES in overlapping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. De novo coronary artery stenosis in a major coronary artery branch (reference diameter
             2.5-4.0 mm) with a lenght &gt;28mm and &lt;39mm

          2. Symptoms or instrumental evidence of myocardial ischemia:

               -  Chronic stable angina [Canadian Cardiovascular Society Classification]

               -  Unstable angina with ECG changes or troponin release (Braunwald Class IB-C,
                  IIB-C, or IIIB-C)

               -  Stress ECG or myocardial perfusion imaging or stress echocardiography positive
                  for inducible myocardial ischemia

          3. Written informed consent to the study

        Exclusion Criteria:

          1. Pregnancy or lactation

          2. Acute ST elevation myocardial infarction (primary angioplasty)

          3. Cardiogenic shock

          4. Known allergic reactions to aspirin, clopidogrel, prasugrel, heparin, enoxaparin,
             bivalirudin, steel, chromium, iodiate contrast medium

          5. Platelets &lt;75.000/mm3 or &gt;700.000/mm3 or white blood cells &lt;3.000/mm3.

          6. Partecipation to other studies.

          7. Active or &lt;3 months peptic ulcer or gastrointestinal bleeding

          8. Planned major surgery non delayable .

          9. Comorbidities limiting life expectancy to &lt;1 year.

         10. Unprotected left main disease as target lesion

         11. Chronic total occlusion as target lesion

         12. Bifurcation with side branch &gt; 2.5mm as target lesion

         13. Restenosis as target lesion

         14. saphenous vein graft as target lesion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandro Lupi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOU Maggiore della Carità - Novara</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angelo S Bongo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AOU Maggiore della Carità - Novara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Lupi, MD</last_name>
    <phone>+3903213733236</phone>
    <email>lupialessandro1@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Lupi, MD</last_name>
      <phone>+3903213733236</phone>
      <email>lupialessandro1@tin.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Lupi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Rognoni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://rocco.zeusdatapower.com</url>
    <description>electronic CRF URL</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2012</study_first_submitted>
  <study_first_submitted_qc>October 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2012</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero Universitaria Maggiore della Carita</investigator_affiliation>
    <investigator_full_name>Lupi Alessandro</investigator_full_name>
    <investigator_title>Dr Alessandro Lupi, Cardiologia Ospedaliera, AOU Maggiore della Carità, Novara.</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>bioabsorbable polymer</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>restenosis</keyword>
  <keyword>late thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

